85 New COVID-19 Cases Since Last Wednesday at Noon
& 5 Deaths Reported
51,419 Total Positive Cases & 1,197 Total Deaths
MOHAVE COUNTY, AZ (March 16, 2022) — The Mohave County Health Department (MCDPH) Nursing staff has been notified of 85 new confirmed COVID-19 cases reported since last Wednesday at noon. There are also 5 newly reported deaths. ALL 5 of those deaths are the result of previously reported positive cases. Details are below.
ALL 85 new confirmed positive cases remain under investigation.
TOTAL RECOVERED THUS FAR: 36,992
AVERAGE AGE OF CASES SINCE CASE #1: 44.8
AVERAGE AGE OF DEATHS SINCE FIRST DEATH: 72.0
**COVID-19 Reports Now Take Place Only on Wednesdays**
Latest Mohave County Stats: Decrease in New Cases and Positivity Rates • Mohave County had 1,339 new confirmed cases in February 2022, this is a 90.44% decrease from January. • Positivity decreased to 15.5 in February from the January peak of 47.9% Decrease in School-Age Children Cases • Early in February, COVID-19 cases remained high
in school-age children; however, with the decrease in overall cases these numbers decreased later in the month.
Omicron Variant Prevalence • The Omicron variants presence remains high in Mohave County and has increased by 1% from January. Making Omicron and its sublinages the most prevalent variant in the county. The largest percentage of deaths came from the 80-89 age group with 31% followed by the 70-79 age group with 28%. 299 hospitalizations of COVID-19 positive patients were reported in February. This is a 12.4% increase from the 264 hospitalizations reported in January.
The average age of COVID-19 hospitalizations in Mohave County is 67.1 years old. As with the average age of cases and deaths, the average age of hospitalization also increased from January to February (65.4 in January to 67.1 years old in February). The largest percentage of hospitalizations in February were from the 60-69 age group (35%).
Compared to the weekly January count of 1,117, the number of school-aged cases decreased in February to 439.
The week of February 5th saw a peak in cases with 324 new cases in school- aged children. 59% of school-aged cases between the first and last week of February were from the 5-13-year-old age group. Since the start of the pandemic, 395,674 PCR tests have been conducted in Mohave County with an overall percent positivity of 15.5%. The current percent positivity in Mohave County remains in the high category.
Throughout February, approximately 4,095 PCR tests were conducted each week in the county. Testing is considered underreported as individuals who purchase and
administer over-the-counter antigen tests do not report positive test results to the state or county. Testing, Vaccination, and Breakthrough Infection Trends Since the start of the pandemic, 395,674 PCR tests have been conducted in Mohave County with an overall percent positivity of 15.5%.
The current percent positivity in Mohave County remains in the high category. Throughout February, approximately 4,095 PCR tests were conducted each week in the county. Testing is considered underreported as individuals who purchase and administer over-the-counter antigen tests do not report positive test results to the state or county. 46% of Mohave County residents have received at least one dose of the COVID-19 vaccine, according to the ADHS Data Dashboard. The statewide vaccination percentage is 68.5%. <20
years old continue to have the lowest vaccination rate in Mohave County, with only 10.9% vaccinated; however, this is an increase from the previous month. The 65+ age group has the highest vaccination percentage at 70.2%.
The majority of COVID-19 positive cases continue to be among the unvaccinated population. In December and January, 80.4% and 76.1% of cases (respectively) were not fully vaccinated at the time of diagnosis. High transmission of the virus among unvaccinated individuals also leads to an increased risk of vaccine breakthrough cases. A vaccine breakthrough is a case who tested positive after receiving both doses of a two-dose vaccine series, or one-dose of a single dose series, and it has been longer than two weeks since the last dose.
Based on AHDS vaccine breakthrough data, there were 392 breakthroughs in the month of February. This is 29% of all total cases reported in February. The number of vaccine
breakthrough cases has been increasing, which illustrates the need for eligible individuals to receive a booster dose. Listed below is the ADHS definition of a vaccine breakthrough. Note that this data does not classify fully vaccinated individuals as those who have received both a primary series and a booster.
ADHS defines vaccination breakthrough infection as: “A vaccine breakthrough case is an Arizona resident who has SARS-CoV-2 detected on a respiratory specimen collection more than 14 days after completing the primary series of an FDA authorized SARS-CoV-2 vaccine.”
Protect yourself and others
• Get Vaccinated
• Wear a mask in areas of substantial or high transmission
• Stay 6 feet away from others
• Avoid crowds and poorly ventilated spaces
• Wash your hands often
• Clean and disinfect high touch surfaces
• Cover coughs and sneezes
• Test to prevent the spread to others
• Monitor your health daily – Be alert for symptoms
For more detailed information, please visit https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html
ADHS has launched a new website for treatments in Arizona to complement the current monoclonal antibodies website.
ADHS – Everyone – Monoclonal Antibodies (mAbs) (azdhs.gov)
ADHS – Everyone – Find Treatment (azdhs.gov)
ADHS – Everyone – Antivirals (azdhs.gov)
While vaccines provide the best protection from COVID-19, treatment options such as Monoclonal Antibody therapy can shorten the duration of symptoms and reduce the risk of
severe illness and hospitalization. Monoclonal antibodies, or mAbs, are made in a laboratory to fight a particular infection — in this case, the virus that causes COVID-19 — and are given to patients directly with an infusion or a shot. Your body naturally makes antibodies to fight infection. However, your body may not have antibodies designed to recognize a new virus-like the virus that causes COVID-19.
That’s why mAb treatment may help patients at high risk for severe symptoms or hospitalization. The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to allow the use of monoclonal antibody therapies for the treatment of mild to moderate COVID19 in certain high-risk patients. Some people who have been exposed to COVID-19 may qualify for treatment even before testing positive for COVID-19.
This treatment is not a substitute for vaccination against COVID-19. General eligibility information is below.
• Individuals who have tested positive for COVID-19 and are within ten days of onset
• Unvaccinated individuals who have had close contact with a COVID positive person
• Vaccinated individuals who are immunocompromised and have had close contact with a COVID-positive person
• Each facility has its standards for administering Monoclonal Antibody Therapy. Please visit their respective websites or call the number provided below for more information.
Kingman Regional Medical Center (KRMC)
Website: Seeking Medical Care For Covid-19 | KRMC | Kingman Regional Medical Center (azkrmc.com)
Phone Number: 928-681-8699
Western Arizona Regional Medical Center (WARMC)
Phone number: 928-763- 2273
Havasu Urgent Care (aka Havasu Primary Care and Pediatrics)
Phone number: 928-505-1030
Veklury® (Remdesivir) (FDA approved)
Veklury® (Remdesivir) works by slowing the replication of the COVID-19 virus, thereby reducing the amount of virus circulating in the body. Veklury® (Remdesivir) is approved for
hospitalized patients age 12 years and older who weigh at least 88 pounds, with more severe COVID-19 disease. Your hospital care team will decide if you are eligible to receive this treatment.
Additional COVID-19 Questions?, Please Call 928-753-8665